Kiwi, I am not sure why HDG is unwilling to see the value of winning this lawsuit. You listened to the rehearing arguments the same as I did. I didn't hear anything that would lead me to believe that GSK wasn't going to win. According to 8, if GSK wins Amarin will win. I don't think any other generic would attempt to come to market after that. Sleven,
a.) The Eagle Doesn't Catch Flie b.) Do you think Vascepa (with cardio limitation on label till Dec 13, 2019) was not used / was not usable for cardiac benefit under 500 trigs ...? Acc. to my best, non-pettifogger knowledge prescribers could write, patient could use any drug for any indication ... independently from the label